Brief: Sanbio Group Announced Acquisition Of A Patent Portfolio Regarding Cell Medicines Derived From Mesenchymal Stem Cells
03/09/2018 03:32
Sept 2 (Reuters) - SanBio Co Ltd 4592.T :
* SANBIO GROUP SAYS ANNOUNCED ACQUISITION OF A PATENT
PORTFOLIO
REGARDING CELL MEDICINES DERIVED FROM MESENCHYMAL STEM CELLS
Source text for Eikon: urn:newsml:reuters.com:*:nBw2GRryza
Further company coverage: 4592.T
((Reuters.Briefs@thomsonreuters.com;))